May 12, 2021
Ono President Gyo Sagara Ono Pharmaceutical President Gyo Sagara on May 11 questioned the health ministry’s plan to apply yet another re-pricing for its flagship PD-1 inhibitor Opdivo (nivolumab) after repeated price cuts over the past years. “It would be...read more